text_1: Women who quit hormone therapy still live with cancer risk
text_2: "This story reports on an article published in this week’s Journal of the American Medical Association. The article presents follow-up data from the landmark Women’s Health Initiaive on the risks and benefits of hormone therapy. The new data shows that at three years after stopping hormone therapy, there was no increased risk of heart disease in the hormone therapy group, however the increase in breast cancer risk did persist at three years. The story does not provide adequate details about alternatives to hormone therapy for menopausal symptoms or about lower-hormone options that could potentially confer less risk. The story does not quantify the risks of hormone therapy, in absolute terms or otherwise. This is particularly important for this subject because the risks involved are realtively small. For example, in the study, the risk of breast cancer was less than one half of one percent per year in the hormone therapy group. Furthermore, other than to describe the study as ""sweeping"", the story does not adequately describe the strength of the new evidence. Most importantly, the story does not explain that these findings do not necessarily apply to younger women who take hormone therapy for shorter periods of time. Overall, in focusing solely on the risks of hormone therapy, this story implies that it is not a reasonable choice for women. In reality, when taken by women who are actively experiencing symptoms for short periods of time, hormone therapy is safe and effective."